Niacin ER combinations effective in lipid metabolism disorders

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1614, 2007-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Niacin extended-release/ lovastatin: combination therapy for lipid disorders

By Moon Yong SK Kashyap Moti L

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1763-1771

Informa Healthcare

Access to resources Recommend Favorite

Niacin Extended Release (ER)/Simvastatin (Simcor®): A Guide to its Use in Lipid Regulation

By Lyseng-Williamson Katherine A.

Drugs in R&D, Vol. 10, Iss. 4, 2010-11 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite

Niacin: a lipid polypill?

By Kostner Karam Gupta Soneil

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2911-2920

Informa Healthcare

Access to resources Recommend Favorite

Antioxidant Therapy and Drugs Interfering with Lipid Metabolism: Could They Be Effective in NAFLD Patients?

Current Pharmaceutical Design, Vol. 19, Iss. 29, 2013-09 ,pp. : 5297-5313

Bentham Science Publishers

Access to resources Recommend Favorite

Niacin/laropiprant offers a lipid-altering experience

Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite